Home
About
Publications Trends
Recent Publications
Expert Search
Archive
chromosomal translocation
How Does Chromosomal Translocation Contribute to Cancer?
Chromosomal translocations can activate
oncogenes
or inactivate
tumor suppressor genes
, leading to uncontrolled cell proliferation. For instance, the translocation between chromosome 9 and chromosome 22 results in the formation of the
Philadelphia chromosome
, which is associated with
Chronic Myeloid Leukemia (CML)
.
Frequently asked queries:
What is Chromosomal Translocation?
How Does Chromosomal Translocation Contribute to Cancer?
What Are the Main Components of the Plan?
How Can One Ensure Food Safety?
What are the recommended guidelines for alcohol consumption?
How are Microbiological Cultures Used in Cancer Research?
What are the Benefits of Multidisciplinary Meetings?
What Are Innovative Drug Formulations?
What are Drug Conjugates?
What is the Future of Research on Chromosomal Instability?
Can Emotional Health Affect Cancer Recurrence?
Why is Genetic Heterogeneity Important?
How Do Pathologists Contribute to Cancer Diagnosis?
What is Digital Imaging in Cancer?
How do Secondary Cancers Develop?
Are There Any Risks Associated with Swallowing Exercises?
How Do Patients Access Cancer Drugs?
How Do Therapeutic Vaccines Work?
How are Cognitive Issues Diagnosed?
What Are the Challenges of Using AI in Cancer Care?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe